TY - JOUR
T1 - 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence
AU - Wang, Jin
AU - Shan, Qungang
AU - Liu, Yong
AU - Yang, Hao
AU - Kuang, Sichi
AU - He, Bingjun
AU - Zhang, Yao
AU - Chen, Jingbiao
AU - Zhang, Tianhui
AU - Glaser, Kevin J.
AU - Zhu, Cairong
AU - Chen, Jun
AU - Yin, Meng
AU - Venkatesh, Sudhakar K.
AU - Ehman, Richard L.
N1 - Funding Information:
Contract grant sponsor: National Natural Science Foundation of China; Contract grant number: 81271562 (to J.W.); Contract grant sponsor: Science and Technology Program of Guangzhou, China; Contract grant number: 01704020016 (to J.W.); Contract grant sponsor: National Institutes of Health (NIH); Contract grant numbers: EB001981 (to R.L. E.) and EB017197 (to M.Y.) to design and conduct the study and collect, manage, and analyze the data.
Publisher Copyright:
© 2018 International Society for Magnetic Resonance in Medicine
PY - 2019/3
Y1 - 2019/3
N2 - Background: Preoperative prediction of tumor recurrence is important in the management of patients with hepatocellular carcinoma (HCC). Purpose: To investigate whether tumor stiffness derived by magnetic resonance elastography (MRE) could predict early recurrence of HCC after hepatic resection. Study Type: Retrospective. Population: In all, 99 patients with pathologically confirmed HCCs after surgical resection. Field Strength/Sequence: 3.0T; preoperative MRE with 60-Hz mechanical vibrations using an active acoustic driver. Assessment: Regions of interest (ROIs) were manually drawn in the tumors to measure mean tumor stiffness. Surgical specimens were reviewed for histological grade, capsule, vascular invasion, and surgical margins. The early recurrence of HCC was defined as that occurring within 2 years after resection. Statistical Tests: Cox proportional hazard models were used to evaluate risk factors associated with the time to early recurrence. Results: HCCs with recurrence had higher tumor stiffness, higher rate of advanced T stage, vascular invasion, lower rate of capsule formation, larger tumor size, higher aspartate aminotransferase (AST), and hepatitis B virus (HBV)-DNA level and aspartate aminotransferase / alanine aminotransferase ratio (P = 0.031, 0.007, 0.01, <0.001, 0.015, 0.034, 0.01, and 0.014, respectively) than HCCs without recurrence. Vascular invasion (hazard ratio [HR] = 2.922; 95% confidence interval [CI]: [1.079, 7.914], P = 0.035) and mean tumor stiffness (HR = 1.163; 95% CI: [1.055, 1.282], P = 0.002) were risk factors associated with early recurrence. Each 1-kPa increase in tumor stiffness was associated with a 16.3% increase in the risk for tumor recurrence. Data Conclusion: The mean stiffness of HCCs may be a useful, noninvasive, quantitative biomarker for the prediction of early HCC recurrence after hepatic resection. Level of Evidence: 4. Technical Efficacy: Stage 5. J. Magn. Reson. Imaging 2019;49:719–730.
AB - Background: Preoperative prediction of tumor recurrence is important in the management of patients with hepatocellular carcinoma (HCC). Purpose: To investigate whether tumor stiffness derived by magnetic resonance elastography (MRE) could predict early recurrence of HCC after hepatic resection. Study Type: Retrospective. Population: In all, 99 patients with pathologically confirmed HCCs after surgical resection. Field Strength/Sequence: 3.0T; preoperative MRE with 60-Hz mechanical vibrations using an active acoustic driver. Assessment: Regions of interest (ROIs) were manually drawn in the tumors to measure mean tumor stiffness. Surgical specimens were reviewed for histological grade, capsule, vascular invasion, and surgical margins. The early recurrence of HCC was defined as that occurring within 2 years after resection. Statistical Tests: Cox proportional hazard models were used to evaluate risk factors associated with the time to early recurrence. Results: HCCs with recurrence had higher tumor stiffness, higher rate of advanced T stage, vascular invasion, lower rate of capsule formation, larger tumor size, higher aspartate aminotransferase (AST), and hepatitis B virus (HBV)-DNA level and aspartate aminotransferase / alanine aminotransferase ratio (P = 0.031, 0.007, 0.01, <0.001, 0.015, 0.034, 0.01, and 0.014, respectively) than HCCs without recurrence. Vascular invasion (hazard ratio [HR] = 2.922; 95% confidence interval [CI]: [1.079, 7.914], P = 0.035) and mean tumor stiffness (HR = 1.163; 95% CI: [1.055, 1.282], P = 0.002) were risk factors associated with early recurrence. Each 1-kPa increase in tumor stiffness was associated with a 16.3% increase in the risk for tumor recurrence. Data Conclusion: The mean stiffness of HCCs may be a useful, noninvasive, quantitative biomarker for the prediction of early HCC recurrence after hepatic resection. Level of Evidence: 4. Technical Efficacy: Stage 5. J. Magn. Reson. Imaging 2019;49:719–730.
KW - hepatocellular carcinoma
KW - histological grade
KW - recurrence
KW - tumor capsule
KW - tumor stiffness
UR - http://www.scopus.com/inward/record.url?scp=85052975091&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052975091&partnerID=8YFLogxK
U2 - 10.1002/jmri.26250
DO - 10.1002/jmri.26250
M3 - Article
C2 - 30260529
AN - SCOPUS:85052975091
SN - 1053-1807
VL - 49
SP - 719
EP - 730
JO - Journal of Magnetic Resonance Imaging
JF - Journal of Magnetic Resonance Imaging
IS - 3
ER -